aid: cellcontrol name: Cellcontrol image: http://static1.squarespace.com/static/6a0765abf0ed5f03edce2ba2/t/6a088a1d4269d7153942c3db/1778944541505/Cell_Control_transparent.png?format=1500w description: Cellcontrol is a biotechnology company developing tunable, armed in vivo CAR‑T cell therapeutics. It focuses on platform technologies for safe and potent cell therapy, offering modular solutions for oncology and hematology. The company aims to advance next‑generation cell therapies with controllable dosing and integrated payloads, targeting solid tumors and improving manufacturing efficiency. url: https://raw.githubusercontent.com/api-evangelist/cellcontrol/refs/heads/main/apis.yml x-type: company x-source: harvest:secondary-market x-tier: profiled x-tier-reason: enrichment pass 2026-10-07 (modular-v1; was harvest) specificationVersion: '0.20' created: '2026-10-07' modified: '2026-10-07' tags: - Biotechnology - Cell Therapy - CAR-T - Therapeutics - Company maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: Hosts url: hosts/cellcontrol-hosts.yml - type: Vendors url: vendors/cellcontrol-vendors.yml - type: Leadership url: https://cellcontrolbio.com/team - type: DomainSecurity url: security/cellcontrol-domain-security.yml - type: Website url: https://cellcontrolbio.com apis: - name: CellControl API description: CellControl provides biotech data services. humanURL: https://cellcontrolbio.com baseURL: null properties: [] x-coverage: state: none reason: no-developer-program detail: No public developer documentation or machine-readable contract was found on the company's website or API host. evidence: - url: https://api.cellcontrolbio.com/openapi.json status: 0 checked: '2026-10-07' aid: cellcontrol:cellcontrol-api x-coverage: state: none reason: no-developer-program method: derived generated: '2026-10-07' generator: derive-coverage.py (pre-flight evidence) detail: the company publishes no developer documentation host and no machine-readable contract on its own domain evidence: - url: https://cellcontrolbio.com status: 200 - url: https://equityzen.com/company/cellcontrol status: 403 x-enrichment: date: '2026-10-07' status: enriched artifacts_added: 5 pass: modular-v1 engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local